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Cardamonin inhibits COX and iNOS expression via inhibition of p65NF-κB nuclear 
translocation and Iκ-B phosphorylation in RAW 264.7 macrophage cells 
 
ABSTRACT 
Cardamonin, a chalcone isolated from the fruits of a local plant Alpinia rafflesiana, has 
demonstrated anti-inflammatory activity in cellular models of inflammation. In this report, 
we evaluated the ability of cardamonin to suppress both NO and PGE2 synthesis, iNOS and 
COX-2 expression and enzymatic activity, and key molecules in the NF-κB pathway in order 
to determine its molecular target. Cardamonin suppressed the production of NO and PGE2 in 
interferon-γ (IFN-γ)- and lipopolysaccharide (LPS)-induced RAW 264.7 cells. This inhibition 
was demonstrated to be caused by a dose-dependent down-regulation of both inducible 
enzymes, iNOS and COX-2, without direct effect upon iNOS or COX-2 enzyme activity. 
Subsequently we determined that the inhibition of inducible enzyme expression was due to a 
dose-dependent inhibition of phosphorylation and degradation of I-κBα, which resulted in a 
reduction of p65NF-κB nuclear translocation. We conclude that cardamonin is a potential 
anti-inflammatory drug lead that targets the NF-κB pathway.  
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